美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA078302"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
63629-2415-1 63629-2415 HUMAN PRESCRIPTION DRUG Buspirone Hydrochloride buspirone hydrochloride TABLET ORAL 20210224 N/A ANDA ANDA078302 Bryant Ranch Prepack BUSPIRONE HYDROCHLORIDE 30 mg/1 60 TABLET in 1 BOTTLE (63629-2415-1)
63629-2414-1 63629-2414 HUMAN PRESCRIPTION DRUG Buspirone Hydrochloride buspirone hydrochloride TABLET ORAL 20210224 N/A ANDA ANDA078302 Bryant Ranch Prepack BUSPIRONE HYDROCHLORIDE 30 mg/1 500 TABLET in 1 BOTTLE (63629-2414-1)
69584-094-18 69584-094 HUMAN PRESCRIPTION DRUG Buspirone Hydrochloride buspirone hydrochloride TABLET ORAL 20200501 N/A ANDA ANDA078302 Oxford Pharmaceuticals, LLC BUSPIRONE HYDROCHLORIDE 30 mg/1 180 TABLET in 1 BOTTLE (69584-094-18)
69584-094-06 69584-094 HUMAN PRESCRIPTION DRUG Buspirone Hydrochloride buspirone hydrochloride TABLET ORAL 20200501 N/A ANDA ANDA078302 Oxford Pharmaceuticals, LLC BUSPIRONE HYDROCHLORIDE 30 mg/1 60 TABLET in 1 BOTTLE (69584-094-06)
69584-094-50 69584-094 HUMAN PRESCRIPTION DRUG Buspirone Hydrochloride buspirone hydrochloride TABLET ORAL 20200501 N/A ANDA ANDA078302 Oxford Pharmaceuticals, LLC BUSPIRONE HYDROCHLORIDE 30 mg/1 500 TABLET in 1 BOTTLE (69584-094-50)
72162-1927-5 72162-1927 HUMAN PRESCRIPTION DRUG Buspirone Hydrochloride buspirone hydrochloride TABLET ORAL 20200501 N/A ANDA ANDA078302 Bryant Ranch Prepack BUSPIRONE HYDROCHLORIDE 30 mg/1 500 TABLET in 1 BOTTLE (72162-1927-5)
72162-1927-6 72162-1927 HUMAN PRESCRIPTION DRUG Buspirone Hydrochloride buspirone hydrochloride TABLET ORAL 20200501 N/A ANDA ANDA078302 Bryant Ranch Prepack BUSPIRONE HYDROCHLORIDE 30 mg/1 60 TABLET in 1 BOTTLE (72162-1927-6)
72789-142-01 72789-142 HUMAN PRESCRIPTION DRUG Buspirone Hydrochloride buspirone hydrochloride TABLET ORAL 20201106 N/A ANDA ANDA078302 PD-Rx Pharmaceuticals, Inc. BUSPIRONE HYDROCHLORIDE 30 mg/1 100 TABLET in 1 BOTTLE, PLASTIC (72789-142-01)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase